National News / 'Corbevax' vaccine approved for 18+, can be used as booster dose

Zoom News : Jun 04, 2022, 06:26 PM
New Delhi: The COVID-19 vaccine Corbevax has been approved for booster doses for people aged 18 years and above. Biological E, which manufactures the vaccine, gave this information. Earlier, in late April, the Drugs Controller General of India had given permission for emergency use of Corbevax for children aged 5 to 12 years.

In March this year, when the vaccination of children aged 12 to 14 years was started in India, the Corbevax vaccine was used. Under the vaccination program of the government, its price was fixed at Rs 145.

Biologicals E formed an alliance with Texas Children's Hospital and Baylor College of Medicine in the manufacture of Corbevax. In Phase III human trials, Corbevax demonstrated a better immune response than Covishield against the delta version of the coronavirus, Evans said. Its effect was found to be more than 80 percent against the Delta variants of Corona

Corbevax vaccine is administered intramuscularly. Two doses are given at an interval of 28 days. CORBEVAX is available in 0.5 ml (single dose) and 5 ml (ten doses) vials. It is preserved at 2 to 8 °C.

Explain that due to the sub-variants BA.4 and BA.5 of the Omicron variant, cases of corona virus infection have increased rapidly in some areas of the country. For its prevention, health experts have advised to increase the speed of Kovid vaccination and take a booster dose. So that we can get better immunity against new variants of Corona.